Recursion Pharmaceuticals, Inc. (RXRX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$3.43
-1.58%
Mkt Cap $1.57B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $24.54M | $35.35M | +44.04% | -$0.28 | -$0.21 | +25.00% | — | — |
| Q4 2025 Nov 5, 2025 | $24.56M | $5.17M | -78.93% | -$0.38 | -$0.36 | +5.26% | — | — |
| Q3 2025 Aug 5, 2025 | $19.93M | $19.10M | -4.13% | -$0.35 | -$0.41 | -17.14% | — | — |
| Q2 2025 May 5, 2025 | $13.96M | $14.74M | +5.62% | -$0.44 | -$0.50 | -13.64% | — | — |
| Q1 2025 Feb 28, 2025 | $19.04M | $4.51M | -76.31% | -$0.44 | -$0.53 | -20.45% | — | — |
| Q4 2024 Nov 6, 2024 | $18.17M | $26.08M | +43.53% | -$0.33 | -$0.34 | -3.03% | — | — |
| Q3 2024 Aug 8, 2024 | $13.26M | $14.42M | +8.73% | -$0.35 | -$0.40 | -14.29% | — | — |
| Q2 2024 May 9, 2024 | $12.65M | $13.79M | +9.04% | -$0.43 | -$0.39 | +9.30% | — | — |
| Q1 2024 Feb 27, 2024 | $20.35M | $10.89M | -46.48% | -$0.46 | -$0.40 | +13.04% | — | — |
| Q4 2023 Nov 9, 2023 | $20.53M | $10.10M | -50.79% | -$0.38 | -$0.43 | -13.16% | — | — |
| Q3 2023 Aug 8, 2023 | $11.91M | $11.02M | -7.51% | -$0.38 | -$0.38 | +0.00% | — | — |
| Q2 2023 May 8, 2023 | $14.44M | $12.13M | -15.97% | -$0.34 | -$0.34 | +0.00% | — | — |
| Q1 2023 Feb 27, 2023 | $23.80M | $13.68M | -42.54% | -$0.15 | -$0.31 | -106.67% | — | — |
| Q4 2022 Nov 8, 2022 | $6.84M | $13.05M | +90.74% | -$0.36 | -$0.35 | +2.78% | — | — |
| Q3 2022 Aug 9, 2022 | $5.33M | $7.65M | +43.49% | -$0.35 | -$0.38 | -8.57% | — | — |
| Q2 2022 May 10, 2022 | $83.95M | $5.30M | -93.69% | $0.51 | -$0.33 | -164.71% | — | — |
| Q1 2022 Mar 23, 2022 | $6.03M | $2.50M | -58.56% | -$0.30 | -$0.38 | -26.67% | — | — |
| Q4 2021 Nov 10, 2021 | $2.53M | $2.50M | -1.34% | -$0.28 | -$0.28 | +0.00% | — | — |
| Q3 2021 Aug 13, 2021 | $2.55M | $2.50M | -1.92% | -$0.23 | -$0.31 | -34.78% | — | — |
| Q2 2021 May 12, 2021 | — | $2.50M | — | — | -$0.18 | — | — | — |
| Q2 2021 Apr 16, 2021 | — | $2.55M | — | — | -$0.15 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | $862.00K | — | — | -$0.14 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $186.00K | — | — | -$0.11 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | $60.00K | — | — | -$0.11 | — | — | — |